Catabasis Pharma (CATB) Tops Q4 EPS by 6c

Catabasis Pharma (NASDAQ: CATB) reported Q4 EPS of ($0.63), $0.06 better than the analyst estimate of ($0.69).

For earnings history and earnings-related data on Catabasis Pharma (CATB) click here.

You May Also Be Interested In

• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Wolfspeed (WOLF) Misses Q4 EPS by 174c; Offers Guidance
• Analog Devices climbs as fiscal Q3 results, Q4 outlook beat forecasts